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Objective: Our objective was to investigate relationships between proximal tibial subchondral bone
mineral density (BMD) and nocturnal pain in patients with knee osteoarthritis (OA).
Methods: The preoperative knee of 42 patients booked for knee arthroplasty was scanned using quan-
titative computed tomography (QCT). Pain was measured using the Western Ontario and McMaster
Universities Arthritis Index (WOMAC) and participants were categorized into three groups: ‘no pain’,
‘moderate pain’, and ‘severe pain’ while lying down at night. We used depth-speciﬁc image processing to
assess tibial subchondral BMD at normalized depths of 0e2.5 mm, 2.5e5.0 mm and 5e10 mm relative to
the subchondral surface. Regional analyses of each medial and lateral plateau included total BMD and
maximum BMD within a 10 mm diameter core or ‘focal spot’. The association between WOMAC pain
scores and BMD measurements was assessed using Spearman's rank correlation. Regional BMD was
compared pairwise between pain and no pain groups using multivariate analysis of covariance using age,
sex, and BMI as covariates and Bonferroni adjustment for multiple comparisons.
Results: Lateral focal BMD at the 2.5e5 mm depth was related to nocturnal pain (r ¼ 0.388, P ¼ 0.011).
The lateral focal BMD was 33% higher in participants with ‘severe pain’ than participants with ‘no pain’ at
2.5e5 mm depth (P ¼ 0.028) and 32% higher at 5e10 mm depth (P ¼ 0.049). There were no BMD dif-
ferences at 0e2.5 mm from the subchondral surface.
Conclusion: This study suggests that local subchondral bone density may have a role in elucidating OA-
related pain pathogenesis.
Crown Copyright © 2015 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society
International. All rights reserved.Introduction
Knee osteoarthritis (OA) is a leading cause of chronic pain and
disability in the elderly1. Pain is the dominant symptom of OA2 and
is often the ﬁrst indication that patients may be afﬂicted with OA.
OA-related pain is complex3,4, as it is a combination of social,
psychological, and biological factors, with no simple unitaryJ.D. Johnston, Department of
57 Campus Dr., Saskatoon, SK
nston).
evier Ltd on behalf of Osteoarthritconcept linking symptoms with structural damage5. Within the
joint structure, pain could be due to the presence of various
contributing factors (e.g., altered joint alignment, joint instability,
osteophyte presence both peripherally and within the joint,
inﬂammation, cyst presence, altered subchondral bone properties,
bone marrow lesions (BMLs)). Importantly, underlying sources of
pain may be masked by speciﬁc structural factors, such as altered
joint alignment, osteophyte presence, and inﬂammation, which
would likely present during dynamic weight-bearing activities
such as climbing stairs or walking. To isolate potential underlying
sources of pain, it is advantageous to study pain with non-weight
bearing activities, such as lying in bed at night. Understandingis Research Society International. All rights reserved.
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as nocturnal pain, is also relevant as it is related to sleeplessness
and other disruptions to quality of life in OA patients6.
Knee OA is commonly characterized by subchondral bone
changes, including altered subchondral bone thickness7, bone vol-
ume fraction8 and volumetric density9,10, as well as the presence of
BMLs as observed viamagnetic resonance imaging (MRI)11e13. Little
is known regarding associations between pain and altered sub-
chondral bone morphology or density; however, BML presence and
size have both shown strong associations with knee pain4,13e17. Of
relevance to this study, BMLs have been shown to be associated
with increased bonemineral density (BMD)12 and have higher local
BMD than surrounding bone tissue11. Importantly, altered BMD
may disrupt local innervation18 and/or the local mechanical
behaviour of bone19, and thus may be a factor in OA-related knee
pain.
Our current understanding of the relationship between pain and
altered BMD primarily relies on evidence from studies using two-
dimensional (2D) dual-energy absorptiometry (DXA)20,21. Howev-
er, these studies provide conﬂicting results, reporting that both
higher areal BMD (aBMD)20 and lower aBMD21 are associated with
OA-related pain. These conﬂicting results may be due to the
inherent limitations of 2D projection techniques, such as patient
size and positioning22, unstandardized regions of interest
(ROI)12,21,23, and the inability to evaluate distinct regions or
depths22. Three-dimensional (3D) computed tomography (CT)
based depth-speciﬁc imaging techniques have the ability distin-
guish differences in subchondral volumetric BMD between normal
and OA tibiae10,24, and may have the ability to identify regional
BMD differences in patients with and without pain. Depth-speciﬁc
imaging techniques also have the potential to determine approxi-
mate contrasts between subchondral cortical BMD and less dense
trabecular BMD layers25, which may have different roles in OA-
related pain.
Using a depth-speciﬁc CT-based image processing tool, the
objective of this study was to determine whether there are asso-
ciations between proximal tibial subchondral BMD and OA-related
nocturnal pain.
Methods
Study participants
Fifty-two participants (23M: 29F; mean age 64, SD ± 9.4years)
with OA were recruited prior to total knee replacement. Study
exclusion criteria included: pregnant women, patients having a
revision replacement instead of primary knee replacement, and
patients with a prior history of bone pathology at the knee joint. CT
images with excessive imaging artifacts, motion artifacts, or
incomplete images were excluded, resulting in 42 study partici-
pants (17M: 25F; 64 ± 10 years). The Institutional Research Board of
the New England Baptist Hospital approved the study. Informed
consent was obtained from all study participants.
Knee assesment
OA severity was classiﬁed using KellgreneLawrence grading26
and OA-related pain severity was measured at the affected knee
joint using a 5-point Likert scale (0e4) of the pain subsection of the
Western Ontario McMasters Osteoarthritis Index (WOMAC)27. Par-
ticipants were asked to assess the level of pain in the affected knee
joint within the past 24-h while walking on a ﬂat surface, going up
or down stairs, nocturnal pain at night in bed, sitting or lying down,
and standing upright. This study was focused on non-weight
bearing nocturnal pain at night in bed.To help explain potentially high and low BMD ﬁndings, all CT
scans (including axial, sagittal, and coronal reconstructions) were
retrospectively evaluated for cyst presence, altered knee alignment,
and joint laxity. Cyst size and number was semi-qualitatively
scored using a simple combined scoring system (none, small,
moderate, large) similar to the atlas system of Altman and Gold28
(none, mild, moderate, severe). Knee alignment was characterized
as varus, valgus, and neutral. Joint laxity was identiﬁed based upon
evidence of medial or lateral shifting of the femur relative to the
tibia. A single researcher (JDJ), trained by an experienced ortho-
paedic surgeon who routinely assessed cyst presence and knee
alignment/laxity, performed all scorings.
CT acquisition
We used a single energy clinical CT scanner (LightSpeed 4-slice,
General Electric, Milwaukee, WI, USA) for bone imaging. A solid
quantitative CT (QCT) reference phantom of known bone mineral
densities (Model 3T, Mindways Software Inc., Austin, TX, USA) was
placed under the participants and included in all CT scans. The
phantom was included to convert grayscale CT Hounsﬁeld Units
(HU) to equivalent apparent BMD (mg/cm3 K2HPO4) with both
human and animal studies verifying that QCT density measures are
accurate representations of true BMD29,30. Participants were ori-
ented supine within the CT gantry and both legs were simulta-
neously scanned. Scans included the distal femur, patella, proximal
tibia, and the 66% tibial shaft site proximal to the distal tibial end-
plate31. Only the proximal tibia and the 66% tibial shaft site were
used in the current analysis.
CT scanning parameters included: 120 kVp tube voltage,
150mAs tube current-time product, axial scanning plane, 0.625mm
isotropic voxel size (0.625 slice thickness, 0.625mm 0.625mm in-
plane pixel size), ~250 slices, ~60 sec scan time. A standard bone
kernel (BONE) was used for CT image post-processing. Effective
radiation dosewas ~0.073mSv per scan, estimated using shareware
software (CT-DOSE, National Board of Health, Herley, Denmark). For
comparison, the average effective radiation dose during a trans-
atlantic ﬂight from Europe to North America is about 0.05 mSv32.
CT image analysis
We used an earlier developed depth-speciﬁc image processing
technique (computed tomography topographical mapping of sub-
chondral density, CT-TOMASD)24,33 to measure subchondral prox-
imal tibial subchondral BMD. A single user (WDB) performed all
image processing and segmentations. A precision study was per-
formed on an independent sample using recommended tech-
niques34 and results were compared to previously published results
from another user33. Precision errors (root mean square coefﬁcients
of variation, CV%)34 ranged from 0.7% to 3.6%, and absolute percent
differences in regional mean BMD between both users were all
below 3%.
This method uses surface projection image processing to
quantify volumetric subchondral bone density at user-deﬁned
depths from the subchondral bone surface. Brieﬂy, equivalent
volumetric BMD (mg/cm3 K2HPO4) values were converted from
grayscale HU using subject-speciﬁc linear regression equations
developed from known densities within the QCT phantom included
in each individual axial image (r2 > 0.99) (Matlab 2010b; Math-
Works, Natick, MA, USA)24. Subject-speciﬁc half maximum height
thresholds35 were then determined to deﬁne the proximal tibial
subchondral surface. Serial images were individually segmented
using semi-automatic region growing and manual correction
techniques using commercial software (Analyze10.0; Mayo Foun-
dation, Rochester, MN, USA) and an interactive touch-screen tablet
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3D image volume. Medial and lateral plateau surfaces were then
deﬁned by manually selecting boundary points. Each plateau was
then realigned and reconstructed relative to “best-ﬁt” planes
passing through the deﬁned boundary points (Matlab 2010b) for
surface projection analyses. Previously deﬁned boundary points
were then manually adjusted (using knot points and natural cubic
splines), to ensure that the analysis region did not overlay high-
density cortical edges, the tibial spine, or osteophytes24,33.
To allow for subject-to-subject comparisons, subject-speciﬁc
depth was normalized based on user-deﬁned depth, relative
proximal tibia volume (volume superior to lateral inferior ridge of
the proximal ﬁbular head), and area (both lateral and medial pla-
teaus) by using the following equation:
dss  areass
d aream ¼
volumess
volumem
where volumess/volumem is a relative volume ratio deﬁned by
dividing each subject-speciﬁc proximal tibia volume by the mean
proximal tibia volume of all specimens, areass is the subject-speciﬁc
(segmented) area of the medial and lateral plateaus, aream is mean
area of all subjects, d is the desired user-deﬁned normalized depth
(i.e., 2.5 mm), and dss is the actual subject-speciﬁc depth corre-
sponding to the user-deﬁned normalized depth24.
We evaluated total lateral and total medial plateau BMD, as well
as average maximum BMD of a 10 mm diameter core or ‘focal spot’
which searched each lateral and medial plateau for a maximum
value33 (Fig.1). We included focal analyses to locate small regions of
high-density bone possibly masked by whole compartment ana-
lyses. All analyses were performed at three normalized depths from
the subchondral surface:
(1) 0e2.5 mm, approximating the density of subchondral end-
plate and cortical bone36, (2) 2.5e5mm, approximating the density
of subchondral trabecular bone, and (3) 5e10 mm, approximating
the density of proximal epiphyseal trabecular bone10.Fig. 1. Representative topographical colormaps of proximal tibial BMD at depths of 0e2.5 mm (top row) and 2.5e5 mm (bottom row) in one participant reporting ‘no pain’,
‘moderate pain’, and ‘severe pain’ at night in bed. Regional analysis includes average BMD of the lateral and medial plateaus, and average maximum BMD of a 10 mm diameter focal
spot (shown in upper left-hand image) localized on the maximum value of each lateral and medial plateau.Internal control
We compared cortical cross-sectional area and density of the
tibia shaft (66% of tibia length, proximal from distal tibia plateau)31
to assess possible between-group differences in local (e.g., me-
chanical loading) and systemic factors (e.g., nutrition,medication)37.Statistical analysis
To examine associations between nocturnal pain at night in bed
and proximal tibial subchondral BMD, we used Spearman's rank
correlation. We report Spearman's rank correlation coefﬁcients (r)
for all associations.
We categorized participants into three groups based on their
WOMAC score of pain at night in bed. Patients with a score of 0 or 1
were considered to have ‘no pain’, patients with a score of 2 were
considered to have ‘moderate pain’, and patients with a score of 3
or greater were considered to have ‘severe pain’38. To compare
differences in proximal tibial subchondral BMD across patients
with ‘no pain’ and patients experiencing either ‘moderate pain’ or
‘severe pain’ at night in bed, we used multivariate analysis of
covariance (MANCOVA) and selected age, sex, and BMI as cova-
riates37.We report the F-statistic for BMDmeasures with signiﬁcant
between-group differences. We also performed pair-wise compar-
isons with Bonferroni adjustment for multiple comparisons to
determine individual group differences between pain (‘severe pain’
and ‘moderate pain’) and ‘no pain’ for each BMD measure. We
report mean and standard deviation (SD), adjusted mean differ-
ences, and 95% conﬁdence intervals. We also used MANCOVA to
compare cortical cross-sectional area and density at the tibia shaft
across pain groups, also adjusting for age, sex and BMI37. Statistical
signiﬁcance was deﬁned as P < 0.05, and statistical analyses were
performed using SPSS 21.0 (IBM, Armonk, NY, USA).
Results
The characteristics of study participants, including cyst presence
and joint alignment/laxity, are shown in Table I. Patients had OA
severity of KL grade ranging from 3 to 4. In theWOMAC assessment
of non-weight bearing pain at night in bed, scores ranged from
0 (none) to 4 (extreme). Participants were divided into three groups
based on pain at night in bed: ‘no pain’ (n ¼ 17), ‘moderate pain’
(n ¼ 16), and ‘severe pain’ (n ¼ 9).Spearman's rank coefﬁcients showed a signiﬁcant association
between pain at night in bed and lateral focal BMD at a depth of
2.5e5 mm from the subchondral surface (r ¼ 0.388, P ¼ 0.011).
There were no other signiﬁcant associations between pain scores
and other BMD metrics (Table II).
Table I
Background characteristics and clinical data for study participants and groups
Characteristic All Participants (n ¼ 42) ‘No Pain’ (n ¼ 17) ‘Moderate Pain’ (n ¼ 16) ‘Severe Pain’ (n ¼ 9)
WOMAC (in bed at night) 0 or 1 2 3 or 4
Sex ratio (M:F) 17:25 7:10 7:9 3:6
Age (mean ± SD) 64.1 ± 10.1 67.5 ± 9.1 61.8 ± 11.0 61.8 ± 9.3
BMI (mean ± SD) 28.7 ± 3.7 28.3 ± 4.1 29.1 ± 3.6 28.7 ± 3.0
Side (L:R) 18:24 7:10 6:10 5:4
OA Severity (KL) 3 to 4 3 to 4 3 to 4 3 to 4
Cysts (none/small/moderate/large) 31%/24%/26%/19% 47%/35%/12%/6% 31%/13%/25%/31% 0%/22%/56%/22%
Alignment (varus/neutral/valgus) 67%/14%/19% 71%/24%/6% 75%/6%/19% 44%/11%/44%
Laxity (medial/neutral/lateral) 21%/79%/0% 12%/88%/0% 19%/81%/0% 44%/56%/0%
Table II
Spearman rank correlation coefﬁcients (r) for relationship between BMD measurements and WOMAC pain score while lying down at night. Bolded values indicate P < 0.05
Side Region Depth from subchondral surface
0e2.5 mm 2.5e5 mm 5e10 mm
Medial Total 0.284 (P ¼ 0.069) 0.244 (P ¼ 0.120) 0.218 (P ¼ 0.165)
Focal BMD 0.211 (P ¼ 0.181) 0.223 (P ¼ 0.157) 0.248 (P ¼ 0.113)
Lateral Total 0.290 (P ¼ 0.062) 0.301 (P ¼ 0.053) 0.203 (P ¼ 0.198)
Focal BMD 0.156 (P ¼ 0.323) 0.388 (P ¼ 0.011) 0.290 (P ¼ 0.063)
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group difference in lateral focal BMD at depths of 2.5e5 mm (F
(2,36) ¼ 3.915, P < 0.05) and 5e10 mm (F (2,36) ¼ 3.258, P < 0.05)
from the subchondral surface. Individual group differences showed
that participants with ‘severe pain’ had higher lateral focal BMD
than participants with ‘no pain’ at depths of 2.5e5mm (33% higher;
adjusted mean difference: 114 mg/cm3; 95% CI: 9.6e218 mg/cm3;
P ¼ 0.028) and 5e10 mm (32% higher; adjusted mean difference:
60 mg/cm3; 95% CI: 0.3e120 mg/cm3; P ¼ 0.049) (Table IV). There
were no signiﬁcant differences in focal BMD between groups at
depths of 0e2.5 mm from the subchondral surface, or at the total
lateral or medial plateaus (Fig. 2, Tables III and IV). However, there
was a statistically non-signiﬁcant trend for lower BMD at the
medial plateau (across all depths) across the groups with increasing
pain (Fig. 2, Tables III and IV). At the tibial shaft, there were no
signiﬁcant differences in cortical cross-sectional area (F
(2,36) ¼ 0.208, P > 0.05) or density (F (2,36) ¼ 0.186, P > 0.05)
between groups.Table III
Pair-wise comparison of tibial BMDmeasurements in patients with knee OAwith ‘no pain
difference, percent difference from ‘no pain’, 95% conﬁdence interval (CI), and P-value
Region Depth BMD (mg/cm3 K2HPO4) Adjusted me
No Pain Moderate Pain
Mean ± SD Mean ± SD
Medial plateau
Total 0e2.5 mm 480 ± 93 437 ± 116 53 (10.9%
2.5e5 mm 322 ± 98 296 ± 91 36 (11.0%
5e7.5 mm 203 ± 85 177 ± 61 35 (17.0%
Focal BMD 0e2.5 mm 658 ± 94 631 ± 108 38 (5.6%)
2.5e5 mm 499 ± 130 474 ± 123 37 (7.4%)
5e7.5 mm 347 ± 135 309 ± 94 49 (14.0%
Lateral plateau
Total 0e2.5 mm 339 ± 62 356 ± 112 19 (5.6%)
2.5e5 mm 198 ± 52 214 ± 80 17 (8.4%)
5e7.5 mm 127 ± 38 128 ± 45 0 (0%)
Focal BMD 0e2.5 mm 596 ± 81 602 ± 124 11 (1.8%)
2.5e5 mm 352 ± 80 407 ± 120 61 (17.4%)
5e7.5 mm 193 ± 49 205 ± 60 15 (8.1%)
* Mean values adjusted for age (64.1), sex (1.6), and BMI (28.7).Discussion
Our depth-speciﬁc imaging technique identiﬁed a positive as-
sociation between lateral focal BMD at the 2.5e5 mm depth and
non-weight bearing pain at night in bed. Isolated comparisons
identiﬁed higher lateral focal BMD at depths 2.5e5 mm and
5e10 mm from the proximal tibial subchondral surface in patients
experiencing ‘severe pain’ than in patients experiencing ‘no pain’ at
night in bed. This is the ﬁrst study to assess the relationship be-
tween depth-speciﬁc proximal tibial subchondral BMD and symp-
tomatic OA. These ﬁndings suggest that there may be previously
overlooked characteristics in proximal tibial subchondral BMD,
such as focal BMD at depths greater than 2.5 mm from the sub-
chondral surface, which may have a role in OA-related pain
pathogenesis.
Our ﬁndings are consistent with prior research showing asso-
ciations between pain and subchondral bone, namely BML pre-
sence4,13e17. Recent research has also shown BMLs to have higher’ and ‘moderate pain’while lying down at night, including mean ± SD, adjustedmean
an difference* from No Pain (%) 95% conﬁdence interval (mg/
cm3 K2HPO4)
P-value
Lower limit Upper limit
) 146 41 0.50
) 122 49 0.90
) 102 31 0.57
127 51 0.88
152 77 1.00
) 152 54 0.71
58 96 1.00
44 77 1.00
38 38 1.00
79 100 1.00
28 150 0.29
36 66 1.00
Table IV
Pair-wise comparison of tibial BMD measurements in patients with knee OA with ‘no pain’ and ‘severe pain’ while lying down at night, including mean ± SD, adjusted mean
difference, percent difference from ‘no pain’, 95% conﬁdence interval (CI), and P-value. Bolded values indicate P < 0.05
Region Depth BMD (mg/cm3 K2HPO4) Adjusted mean difference* from No Pain (%) 95% conﬁdence interval (mg/
cm3 K2HPO4)
P-value
No Pain Severe Pain
Mean ± SD Mean ± SD Lower limit Upper limit
Medial plateau
Total 0e2.5 mm 480 ± 93 406 ± 110 76 (15.8%) 186 33 0.27
2.5e5 mm 322 ± 98 251 ± 107 74 (22.7%) 174 26 0.22
5e7.5 mm 203 ± 85 154 ± 80 54 (25.8%) 132 24 0.28
Focal BMD 0e2.5 mm 658 ± 94 595 ± 114 66 (9.9%) 170 39 0.37
2.5e5 mm 499 ± 130 399 ± 148 102 (20.3%) 237 33 0.20
5e7.5 mm 347 ± 135 258 ± 134 90 (25.7%) 211 30 0.21
Lateral plateau
Total 0e2.5 mm 339 ± 62 427 ± 74 85 (25.1%) 6 176 0.07
2.5e5 mm 198 ± 52 261 ± 61 62 (31.2%) 10 133 0.11
5e7.5 mm 127 ± 38 150 ± 38 22 (17.5%) 22 66 0.64
Focal BMD 0e2.5 mm 596 ± 81 652 ± 54 58 (9.7%) 47 163 0.53
2.5e5 mm 352 ± 80 461 ± 71 114 (32.7%) 10 218 0.028
5e7.5 mm 193 ± 49 249 ± 55 60 (31.6%) 0 120 0.049
* Mean values adjusted for age (64.1), sex (1.6), and BMI (28.7).
Fig. 2. Adjusted mean regional BMD of each group (‘no pain’, ‘moderate pain’, and ‘severe pain’) at depths of 0e2.5 mm, 2.5e5 mm, and 5e10 mm from the subchondral surface.
Statistically signiﬁcant differences (P < 0.05) between groups are noted with brackets. Error bars represent 95% conﬁdence intervals.
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tion that higher BMD would be associated with pain is supported
by our ﬁndings. Interestingly, higher BMD was found at depths
greater than 2.5 mm from the subchondral surface in regions
comprised primarily of trabecular bone, which parallels ﬁndings of
BMLs predominantly in trabecular regions16,17. Given that trabec-
ular bone is densely innervated39, it is most likely an initiatory site
for pain. Unfortunately, due to limited data, we are unsure if higher
BMD measures coincide with BML presence. Further research is
needed linking pain, BMD and BMLs using CT and MR co-
registration techniques such as those employed by Lowitz et al.11.
The results of this study give some insight into why the results
from previous studies linking OA-related knee pain and proximal
tibial subchondral bone density are conﬂicting. One study found an
association between high aBMD and pain20, where another found a
relationship between low aBMD and pain21. The reasons for this
disagreement may be due to inherent limitations of DXA. For
example, patient size and positioning sensitivities may affect
aBMD measurements whereby larger and mis-positioned patients
have more bone in the projection direction, resulting in an over-
estimation of aBMD22. Also, there are no standardized ROI with
DXA to evaluate proximal tibial subchondral aBMD, with ROIs
varying in size and placement from study to study12,21,23. These
ROIs most likely contain both subchondral cortical and trabecular
bone. The results of this study suggest that sites distal to the
subchondral surface (which contain primarily trabecular bone)
appear to be most affected by OA. As such, aBMD measures con-
taining both subchondral cortical and trabecular bone may not be
sensitive enough to capture OA-effects on local bone density.
Conversely, by evaluating BMD at speciﬁc depths from the sub-
chondral surface, the depth-speciﬁc imaging technique used in this
study was able to approximate individual effects of OA on regions
composed of mostly mineralized subchondral cortical bone
(0e2.5 mm layer) and trabecular bone (2.5e5 and 5e10 mm
layers).
Another possible reason for disagreement between higher and
lower aBMD and pain may be because previous studies reporting
aBMD appear to have evaluated entire compartments of the prox-
imal tibia20,21. This study found no associations between pain
severity and BMD at the total lateral or medial plateau. Instead, our
ﬁndings suggest that pain may be related to localized BMD differ-
ences11, as indicated by the higher lateral focal ‘spot’ BMD in pa-
tients with ‘severe pain’ vs ‘no pain’ at depths of 2.5e5 mm and
5e10 mm from the subchondral surface. Further investigations,
with depth-speciﬁc imaging techniques capable of measuring
localized BMD, are needed to clarify the role of local subchondral
bone density in OA-related pain.
Our results show higher BMD at the lateral plateau and a ten-
dency for lower BMD at the medial plateau and as pain severity
intensiﬁes. These observations may be due to cyst presence and
associated knee alignment. First, cyst presence may have been
indirectly captured as low BMD measures, especially in the medial
plateau. In this study, many of the individuals with ‘severe pain’ had
CT evidence of cysts (moderate-to large-size and number), focused
predominately in the medial plateau. Conversely, few individuals
with ‘no pain’ had radiographic evidence of cysts of similar size and
number. Interestingly, our BMD measures may be indirectly
reﬂecting cyst size and number. Second, patients with ‘severe pain’
appear to have altered joint alignment and/or evidence of joint
laxity with medial shifting of the femur relative to the tibia.
Conversely, patients with ‘no pain’ had either varus or neutral
alignment, with only one knee in valgus. This malalignment could
result in loading-induced adaptation and lower medial BMD and
higher lateral BMD40. This malalignment may be a consequence of
advancing disease progression41 or a consequence of self-adjustedjoint alignment to help alleviate joint pain caused by other fac-
tors, such as medial cyst presence. Given that the lateral
compartment has a smaller contact area then the medial
compartment, and higher associated contact and interosseous
stresses, it is possible that patients with valgus alignment are
simply more susceptible to severe knee pain. It is possible that
higher lateral BMD has inﬂuenced local innervation18, leading to
pain. Though, as noted earlier, observed higher lateral BMDmay be
a secondary effect caused by medial cyst presence.
Cyst ﬁndings generate an interesting hypothesis to explain why
individuals with ‘severe pain’ had a trend for lower medial bone
density than individuals with ‘no pain’. Severe pain may be partly
due to greater bone resorption and necrotic cyst development, both
manifesting as low BMD. The ‘bony contusion theory’42,43 proposes
that excessive loading or trauma causes trabecular microfractures,
necrotic bone and focal bone resorption, eventually resulting in cyst
development near the subchondral bone surface. Inﬂammatory
macrophages within the lining of cysts are capable of forming into
osteoclasts44, which could promote further bone resorption and
cyst expansion45. Bone surrounding cysts have been reported to be
necrotic and lacking of blood vessels or normal marrow compo-
nents46, which could contribute to pain47. Local subchondral bone
cyst presence is also thought to increase intra-osseous stress
distributions, leading to pain and disability48. Given that cyst vol-
umes range in size from 1 mm3 to 657 mm3 49, which is much
greater than QCT voxel volumes (0.244 mm3 voxel volume;
0.625  0.625  0.625 mm voxel size), there is strong potential to
develop novel QCT-based techniques for quantifying cyst volume
and number to investigate this hypothesis further. However, multi-
modality validation studies (e.g., microCT vs QCT) are ﬁrst needed
to verify that QCT-based techniques isolate cysts from surrounding
subchondral bone and offer accurate measures of cyst size and
number.
Strengths of this study include sample characteristics, the use of
an internal control, normalization of our depth-speciﬁc measure-
ments, and high degree of measurement precision. Our study
sample was a homogeneous group of patients with similar OA
severity and known covariates (age, sex, and BMI) between pain
groups, possibly reducing the effect of possible confounding factors
affecting BMD and pain. Also, we used tibial shaft cortical area and
density measurements to account for possible between-group
differences in systemic and/or local factors that may be associ-
ated with subchondral BMD. All BMD measurements were
normalized according to mean proximal tibial volume and plateau
surface area, and all imaged volumes were rotated and reoriented
in similar 3D orientations relative to manually selected landmark
boundary points and best-ﬁt planes. This permitted reliable com-
parisons between groups. Lastly, we used a precise depth-speciﬁc
image processing technique to assess plateau and focal BMD33.
The observed differences in local BMD between ‘severe pain’ and
‘no pain’ groups were ~7 greater than associated precision er-
rors33, and are therefore trustworthy.
This study has certain limitations. First, pain severity and
assessment was based on the entire knee joint, including all joint
surfaces (tibiofemoral and patellofemoral) and tissues (e.g., bone,
menisci, synovium), and it is uncertain if pain originated at the
proximal tibial surface, other tissues, or a combination of surfaces
and tissues. Second, although OA severity was homogeneous
throughout study participants, all were in late stages of OA and it
may not be possible to apply our ﬁndings to patients with less
severe OA. Third, we used a bone reconstruction kernel (as opposed
to a standard soft-tissue reconstruction kernel) to help distinguish
the subchondral surface and ease segmentation. This reconstruc-
tion kernel may have overestimated BMD values very close to the
subchondral surface. Fourth, our study sample size was small
W.D. Burnett et al. / Osteoarthritis and Cartilage 23 (2015) 1483e1490 1489(n ¼ 42), and with a basic rule of thumb of 10 samples per pre-
dictor50, we were limited to four covariates (BMD, age, sex, BMI)
and could not add additional covariates to our statistical analysis
(e.g., cyst presence, knee alignment). Our small sample, combined
with inherent measurement imprecision (albeit small), also likely
explains why medial BMD, which appeared lower in the pain
groups vs no pain group, did not reach statistical signiﬁcance.
Larger studies should be completed to conﬁrm our ﬁndings and
clarify the relationship between BMD and OA-related pain.
Depth-speciﬁc imaging techniques demonstrated higher lateral
maximum focal BMD in patients with ‘severe pain’, compared to
patients with ‘no pain’ at night in bed, at depths of 2.5e5 mm, and
5e10 mm from the proximal tibial subchondral surface. This study
suggests that deep subchondral bone layers, as opposed to the bone
immediately adjacent to the subchondral surface, may have a role
in OA-related pain pathogenesis.
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